Product Images Gabapentin

This appears to be a figure or table showing the mean pain scores over a period of 8 weeks. The study seems to have a titration period of 4 weeks followed by a fixed dose period of 4 weeks. The two treatments being compared are a placebo and Gabapentin with a maximum dose of 3600mg per day. However, without more context or information it is difficult to make any further conclusions.*

This is a chart representing the mean pain score for a clinical trial of a pain medication with a dose titration period of three weeks and a subsequent fixed dose period of four weeks. The chart includes three groups: a placebo group, a group taking 1800 mg/day of gabapentin, and a group taking 2400 mg/day of gabapentin. The mean pain scores are represented along the y-axis, and the baseline and weeks are listed along the x-axis.*

This appears to be a chart or graph showing percentages of something in Study 1 and Study 2. There are four treatment groups (PBO, GBP 3600, PBO, and GBP 1800) with corresponding percentages at different levels. There are also asterisks denoting statistical significance levels for some of the groups. However, without additional context or a descriptive title, it is difficult to determine the exact nature of what is being studied or reported.*

This is a description of a medication called Gabapentin which comes in the form of an oral solution with a concentration of 250mg/5mL. It is distributed by Amneal Pharmaceuticals LLC and is only available by prescription. The recommended dosage and use details are available in the package insert. The medication should be stored refrigerated at 2-8°C and kept out of reach of children. The net contents of the product are 473ml.*